Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : ABBV save search
AbbVie, Evolus, and Medytox Announce Resolution of Intellectual Property Litigation
Published: 2021-02-19 (Crawled : 17:00) - biospace.com/
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.16%
H: 0.44%
C: -1.15%
EOLS | $11.49 -0.61% -0.61% 350K
|
Health Technology
|
| O: 48.18%
H: 39.59%
C: 15.83%
Junshi and Coherus Biosciences Announce Positive Interim Results of CHOICE-01, a Phase 3 Clinical Trial Evaluating Toripalimab in Combination with Chemotherapy as First-Line Treatment for Non-Small Cell Lung Cancer
Published: 2021-08-19 (Crawled : 02:00) - globenewswire.com
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -0.92%
H: 2.37%
C: 1.48%
CHRS | $2.06 3.0% 2.91% 2.9M
|
Health Technology
|
| O: 1.27%
H: 8.73%
C: 1.47%
treatment lung cancer positive therapy results cancer phase 3 trial
Cabaletta Bio Appoints Biopharmaceutical Leader Scott Brun, M.D. to Board of Directors
Published: 2021-06-28 (Crawled : 16:00) - biospace.com/
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.25%
H: 0.75%
C: -0.23%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: 0.24%
H: 2.98%
C: 2.4%
CABA | $13.31 -4.72% -4.96% 1.2M
|
Health Technology
|
| O: 1.87%
H: 8.33%
C: 6.04%
biopharma
Uveitis Drugs Market, High Prevalence Of Eye Disorders And Associated Risk Factors Of Uveitis to Boost Market Growth - Technavio
Published: 2022-08-08 (Crawled : 22:00) - prnewswire.com
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 1.28%
H: 0.8%
C: 0.13%
BHC | $8.69 1.05% 0.0% 2.9M
|
Health Technology
|
| O: -7.02%
H: 7.55%
C: -4.6%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.24%
H: 1.11%
C: -0.31%
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: -0.56%
H: 1.04%
C: 0.58%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -0.03%
H: 1.02%
C: 0.47%
risk eye growth market
Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Results; Achieves 2023 Financial Guidance
Published: 2024-02-15 (Crawled : 13:00) - biospace.com/
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.48%
H: 1.56%
C: 1.48%
IRWD | $7.94 4.47% 4.28% 2.5M
|
Health Technology
|
| O: -5.63%
H: 7.34%
C: 2.81%
year pharmaceuticals ironwood financial
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published: 2021-03-25 (Crawled : 15:49) - fda.gov
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.11%
H: 0.39%
C: 0.06%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.46%
H: 1.46%
C: 1.15%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 1.12%
H: 0.0%
C: -0.33%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -0.16%
H: 1.21%
C: 0.95%
SUPN | $29.43 1.94% 1.9% 360K
|
Health Technology
|
| O: -0.32%
H: 5.23%
C: 4.43%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.89%
H: 0.5%
C: 0.41%
OTIC | $0.077
|
Health Technology
|
| O: -1.88%
H: 2.3%
C: 0.0%
OMER | $3.045 -5.14% -5.42% 390K
|
Health Technology
|
| O: -1.44%
H: 3.5%
C: 2.24%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.67%
H: 0.15%
C: -1.22%
BMRN | $88.68 -1.54% -1.57% 1.8M
|
Health Technology
|
| O: -0.72%
H: 1.06%
C: 0.76%
BCRX | $4.44 -1.33% -1.35% 4.7M
|
Health Technology
|
| O: -4.08%
H: 7.03%
C: 6.04%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.64%
H: 0.2%
C: -0.32%
Vitiligo Therapeutics Market - Information on Key Vendors Including (Alkem Laboratories Ltd., Bausch Health Companies Inc., Canixa Life Sciences, and more)
Published: 2022-08-25 (Crawled : 11:00) - prnewswire.com
TEVJF | News | $12.37 -24.22% 380
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
ALPMF | $9.17 43.47% 16K
|
Health Technology
|
| O: 1.55%
H: 0.1%
C: 0.1%
ALPMY | $9.47 -1.11% 520K
|
Manufacturing
|
| O: 1.04%
H: 0.62%
C: 0.34%
VTRS A | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: 0.0%
H: 0.49%
C: 0.1%
BAX | $39.47 -0.45% 0.0% 2.8M
|
Health Technology
|
| O: 0.55%
H: 1.56%
C: 1.51%
BHC | $8.69 1.05% 0.0% 2.9M
|
Health Technology
|
| O: 0.95%
H: 6.02%
C: 3.95%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.62%
H: 0.57%
C: 0.4%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.62%
H: 0.02%
C: -0.13%
companies health life therapeutics market
Aspira Women’s Health Announces Fourth Quarter Operational Metrics and Provides Updates on Its OvaWatch and EndoCheck Programs
Published: 2022-01-05 (Crawled : 12:30) - vermillion.com
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -0.01%
H: 0.0%
C: 0.0%
AWH | $3.53 0.71% 7K
|
Health Technology
|
| O: 2.34%
H: 5.71%
C: -8.57%
health women
Kadcyla Leads the Global Antibody Drug Conjugates Market with Extensive Use in Breast Cancer Treatment
Published: 2023-11-01 (Crawled : 18:00) - prnewswire.com
ALPMY | $9.47 -1.11% 520K
|
Manufacturing
|
| O: -1.46%
H: 3.67%
C: 3.26%
ZYME | $8.85 2.08% 2.03% 550K
|
Health Technology
|
| O: 1.14%
H: 0.42%
C: -0.7%
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: 1.03%
H: 0.73%
C: 0.58%
ADCT | $4.72 -0.84% 0.0% 320K
|
Health Technology
|
| O: -0.16%
H: 6.42%
C: 4.49%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -0.86%
H: 0.0%
C: 0.0%
STRO | $3.635 -3.58% -3.71% 520K
|
Health Technology
|
| O: 0.39%
H: 3.86%
C: 3.86%
IMGN | $31.23 0.03% 49M
|
Health Technology
|
| O: 5.09%
H: 5.48%
C: -1.27%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -0.47%
H: 1.88%
C: 1.78%
EXEL | $22.51 0.09% 0.09% 2.3M
|
Health Technology
|
| O: -2.62%
H: 1.17%
C: -1.66%
drug antibody breast cancer treatment global market
Infinity Pharmaceuticals Reports Full Year 2022 Financial Results
Published: 2023-03-28 (Crawled : 21:00) - biospace.com/
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.17%
H: 0.51%
C: 0.29%
MEIP | $3.3 1.54% 1.52% 26K
|
Health Technology
|
| O: 0.42%
H: 1.49%
C: -5.73%
INFI | $0.016 12.5% 1.1M
|
Health Technology
|
| O: 5.74%
H: 5.43%
C: -0.52%
year pharmaceuticals financial results
Global $500+ Mn Neurotrophic Keratitis Markets, 2023-2028: Empowering Vision Health - Neurotrophic Keratitis Market on the Rise
Published: 2023-08-25 (Crawled : 17:00) - prnewswire.com
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.67%
H: 0.37%
C: 0.26%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.51%
H: 0.0%
C: 0.0%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -0.11%
H: 0.44%
C: -0.22%
KALA | $6.81 0.0% 7.6K
|
Health Technology
|
| O: -1.31%
H: 0.85%
C: 0.67%
BBIO | $24.74 -0.84% -0.85% 2M
|
Health Technology
|
| O: 0.71%
H: 5.34%
C: 4.95%
health global market
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published: 2021-06-21 (Crawled : 00:00) - fda.gov
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.18%
H: 1.54%
C: 1.39%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.25%
H: 2.13%
C: 1.63%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 0.21%
H: 0.83%
C: 0.33%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.5%
H: 1.37%
C: 0.91%
XERS | $1.73 -1.7% -1.73% 2M
|
Health Technology
|
| O: 0.24%
H: 0.73%
C: -4.13%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.32%
H: 0.17%
C: -0.13%
OTIC | $0.077
|
Health Technology
|
| O: 0.0%
H: 3.98%
C: -1.33%
OMER | $3.045 -5.14% -5.42% 390K
|
Health Technology
|
| O: 1.39%
H: 0.79%
C: 0.33%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.57%
H: 0.86%
C: 0.54%
BCRX | $4.44 -1.33% -1.35% 4.7M
|
Health Technology
|
| O: 0.5%
H: 4.88%
C: 4.7%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.4%
H: 0.53%
C: 0.25%
AbbVie and REGENXBIO Announce Eye Care Collaboration
Published: 2021-09-13 (Crawled : 11:00) - prnewswire.com
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.67%
H: 1.29%
C: 0.08%
RGNX | $15.67 -2.73% -2.87% 570K
|
Health Technology
|
| O: 21.86%
H: 9.05%
C: 7.66%
CLSD P | $1.29 -2.27% -2.33% 230K
|
Health Technology
|
| O: 0.3%
H: 4.82%
C: 2.72%
eye collaboration
AbbVie Reports Second-Quarter 2023 Financial Results
Published: 2023-07-27 (Crawled : 15:00) - biospace.com/
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 2.13%
H: 4.77%
C: 3.02%
abbvie financial results
Hyperhidrosis Treatment Market to Reach USD 950.7 Million, Globally, by 2031 at 5.1% CAGR: Allied Market Research
Published: 2022-10-13 (Crawled : 12:00) - prnewswire.com
ROIV | $10.46 0.97% 0.96% 4.7M
|
Manufacturing
|
| O: -2.94%
H: 7.46%
C: 7.23%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -1.68%
H: 4.47%
C: 4.07%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -2.34%
H: 4.74%
C: 4.55%
treatment research market
AbbVie and Immunome Announce Strategic Collaboration to Discover Multiple Novel Oncology Targets
Published: 2023-01-06 (Crawled : 13:20) - prnewswire.com
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.83%
H: 1.98%
C: 1.04%
IMNM | $15.5 -9.78% -10.84% 2.1M
|
Health Technology
|
| O: 21.66%
H: 4.71%
C: -17.63%
collaboration
Ironwood Pharmaceuticals Provides Update on FY 2021 Financial Guidance and Announces FY 2022 Financial Guidance
Published: 2022-01-10 (Crawled : 13:30) - biospace.com/
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -0.37%
H: 0.0%
C: 0.0%
IRWD | $7.94 4.47% 4.28% 2.5M
|
Health Technology
|
| O: -3.79%
H: 4.65%
C: 4.29%
Hematology/Oncology (Cancer) Approvals & Safety Notifications
Published: 2021-04-13 (Crawled : 18:40) - fda.gov
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.03%
H: 0.56%
C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.03%
H: 1.03%
C: 0.22%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 0.27%
H: 0.33%
C: 0.09%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -1.85%
H: 0.42%
C: -0.3%
YMAB | $15.15 1.0% 0.99% 470K
|
Health Technology
|
| O: 0.55%
H: 5.75%
C: 4.16%
VSTM | $9.86 -3.62% -3.75% 150K
|
Health Technology
|
| O: -1.85%
H: 2.64%
C: 1.13%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.56%
H: 0.18%
C: -0.4%
RIGL | $1.07 1.91% 1.87% 810K
|
Health Technology
|
| O: -1.66%
H: 9.58%
C: 5.07%
REGN | $896.27 0.26% 0.25% 500K
|
Health Technology
|
| O: 0.2%
H: 1.83%
C: 0.66%
KPTI | $1.16 -9.38% -10.34% 1.4M
|
Health Technology
|
| O: 0.89%
H: 5.1%
C: 0.1%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 0.0%
H: 3.18%
C: 1.93%
ILMN | $117.43 0.63% 0.63% 1.4M
|
Health Technology
|
| O: 0.87%
H: 0.47%
C: -2.11%
EXEL | $22.51 0.09% 0.09% 2.3M
|
Health Technology
|
| O: -0.38%
H: 4.2%
C: 3.09%
EPZM | $1.47 -1.34% 0.0%
|
Health Technology
|
| O: 0.18%
H: 3.17%
C: 0.24%
CLVS | $0.0812 -3.94%
|
Health Technology
|
| O: 0.0%
H: 4.56%
C: 1.79%
BPMC | $86.87 -2.28% -2.34% 800K
|
Health Technology
|
| O: 0.37%
H: 6.32%
C: 3.68%
BGNE | $129.51 -1.86% -1.89% 300K
|
Health Technology
|
| O: 0.24%
H: 2.16%
C: -0.12%
AVEO | $15.0 0.0% 0
|
Health Technology
|
| O: 0.15%
H: 2.63%
C: -0.15%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.01%
H: 0.61%
C: -0.14%
ALNY | $144.315 -0.58% -0.59% 700K
|
Health Technology
|
| O: 0.86%
H: 2.16%
C: 0.66%
AGIO | $29.52 0.31% 0.3% 750K
|
Health Technology
|
| O: 0.73%
H: 4.5%
C: 1.75%
cancer approval
Coherus Announces Positive Results of UDENYCA® On-Body Injector Clinical Trial
Published: 2021-10-05 (Crawled : 13:15) - biospace.com/
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.61%
H: 1.09%
C: 0.11%
CHRS | $2.06 3.0% 2.91% 2.9M
|
Health Technology
|
| O: 0.25%
H: 4.54%
C: 2.02%
positive results positive results trial
AbbVie Seeks New Indication for Migraine Drug Qulipta, Drops Deal with Morphic
Published: 2022-06-22 (Crawled : 16:00) - biospace.com/
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 2.73%
H: 4.44%
C: 2.67%
drug deal migraine
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.